Evidence map›Paper›PMID 38316748›Full record

ArticleNature communications2024

HIV-associated gut microbial alterations are dependent on host and geographic context.

Muntsa Rocafort, David B Gootenberg, Jesús M Luévano, Jeffrey M Paer, Matthew R Hayward, Juliet T Bramante, Musie S Ghebremichael, Jiawu Xu, Zoe H Rogers, Alexander R Munoz and 11 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Cannabis use, microbial diversity, andmedRxiv : the preprint server for health sciences · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Muntsa Rocafort *Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.ORCID 0000-0002-2991-1444
David B Gootenberg *Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.ORCID 0000-0001-5416-106X
Jesús M LuévanoRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.
Jeffrey M PaerRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.
Matthew R HaywardRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.
Juliet T BramanteRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.
Musie S GhebremichaelRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.
Jiawu XuRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.
Zoe H RogersRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.
Alexander R MunozRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.
Samson OkelloDepartment of Medicine, Mbarara University of Science and Technology, 1956, Mbarara, Uganda.ORCID 0000-0001-7377-6094
June-Ho KimHarvard Medical School, Boston, MA, 02114, USA.
Ruth SentongoDepartment of Medicine, Mbarara University of Science and Technology, 1956, Mbarara, Uganda.
Robert WagubiDepartment of Medicine, Mbarara University of Science and Technology, 1956, Mbarara, Uganda.
Alex LankowskiMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, 02114, USA.ORCID 0000-0002-4769-7242
Segametsi MaruapulaDepartment of Family & Consumer Sciences, University of Botswana, 0022, Gaborone, Botswana.ORCID 0000-0002-6203-8384
Guoyan ZhaoDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0000-0001-5615-6774
Scott A HandleyDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0000-0002-2143-6570
Mosepele MosepeleFaculty of Medicine, University of Botswana, 0022, Gaborone, Botswana.
Mark J SiednerHarvard Medical School, Boston, MA, 02114, USA.ORCID 0000-0003-3506-842X
Douglas S KwonRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA. dkwon@mgh.harvard.edu.ORCID 0000-0001-8521-8735

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI RAJESH T GANDHI · 2004 to 2026
$94.4M
The Center for the Global Demography of AgingP30AG024409 · NIA · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI BLOOM, DAVID E · 2004 to 2019
$7.9M
Multi-omics characterization of HIV-associated changes in the gut microbiome and host mucosal immunityR01DK120485 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KWON, DOUGLAS, XAVIER, RAMNIK J · 2018 to 2022
$4.1M
The enteric microbiome in treated and progressive HIV infectionR01DK101354 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KWON, DOUGLAS, VIRGIN, HERBERT W · 2014 to 2018
$3.7M
Quality of Life and Aging with HIV in Rural UgandaR01AG059504 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI SIEDNER, MARK J · 2019 to 2023
$3.4M
Epidemiology of coronary artery disease among people with HIV in rural sub-Saharan AfricaR01HL141053 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SIEDNER, MARK J · 2018 to 2021
$3.0M
The enteric microbiome in HIV-associated chronic immune activation and cardiovascular diseaseR01HL138646 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HANDLEY, SCOTT A., KWON, DOUGLAS · 2017 to 2020
$2.1M
Epidemiology of atherosclerosis among older-age individuals with HIV in UgandaR21HL124712 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SIEDNER, MARK J · 2014 to 2015
$332k
The role of the enteric microbiome in chronic HIV pathogenesis and cardiovascular disease in HIV-infected individualsF30HL136257 · NHLBI · HARVARD MEDICAL SCHOOL · PI GOOTENBERG, DAVID BENJAMIN · 2017 to 2020
$175k
NHLBI NIH HHS F30 HL136257NHLBI NIH HHS R01 HL138646NHLBI NIH HHS R01 HL141053NHLBI NIH HHS R21 HL124712NIAID NIH HHS P30 AI060354NIA NIH HHS P30 AG024409NIA NIH HHS R01 AG059504NIDDK NIH HHS R01 DK101354NIDDK NIH HHS R01 DK120485
6 · The paper itself

Abstract

HIV-associated changes in intestinal microbiota are believed to be important drivers of disease progression. However, the majority of studies have focused on populations in high-income countries rather than in developing regions where HIV burden is greatest. To better understand the impact of HIV on fecal microbiota globally, we compare the fecal microbial community of individuals in the U.S., Uganda, and Botswana. We identify significant bacterial taxa alterations with both treated and untreated HIV infection with a high degree of uniqueness in each cohort. HIV-associated taxa alterations are also significantly different between populations that report men who have sex with men (MSM) behavior and non-MSM populations. Additionally, while we find that HIV infection is consistently associated with higher soluble markers of immune activation, most specific bacterial taxa associated with these markers in each region are not shared and none are shared across all three geographic locations in our study. Our findings demonstrate that HIV-associated changes in fecal microbiota are overall distinct among geographical locations and sexual behavior groups, although a small number of taxa shared between pairs of geographic locations warrant further investigation, highlighting the importance of considering host context to fully assess the impact of the gut microbiome on human health and disease.

Indexed as

Gastrointestinal MicrobiomeHIV InfectionsSexual and Gender MinoritiesBacteriaHomosexuality, MaleHumansMaleSexual Behavior

Identifiers

PMID38316748
PMCPMC10844288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.